tiprankstipranks
Trending News
More News >

Cytek Biosciences price target raised to $8.50 from $8 at Piper Sandler

Piper Sandler raised the firm’s price target on Cytek Biosciences (CTKB) to $8.50 from $8 following quarterly results. The firm keeps an Overweight rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue